Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Levonorgestrel and Ethinyl Estradiol 15.0 mg/0.03 mg vs Reference Product
NCT05282940Phase 1Completed
- Sponsor
- Laboratorios Andromaco S.A.
- Start
- Feb 2022
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of avatrombopag and ethinyl estradiol in contraception (2 arms), sponsored by Laboratorios Andromaco S.A. Primary endpoints: Area under the plasma concentration-time curve from 0 to 72 hours, Maximum plasma concentration and 1 more. Started Feb 2022; status: completed.
02
Drugs
avatrombopagethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT05282940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05282940.